Drug for treatment of spinocerebellar degeneration using GABAB receptor agonist

摘要

PROBLEM TO BE SOLVED: To provide a therapeutic agent that improves ataxia appeared in spinocerebellar degeneration and improves the life level of a patient.SOLUTION: This invention provides a pharmaceutical composition that comprises GABAreceptor agonist and is administered as a single agent, for treating spinocerebellar degeneration (excluding one accompanied by spastic paralysis).